WAT
WATERS CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$459.90
+2.31%Forward multiples
Based on analyst estimates
- P/E forward
- 28.72x
- P/E 2026E
- 32.17x
- P/E 2027E
- 28.43x
- P/E 2028E
- 25.41x
- P/S forward
- 6.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- 114.40x
- PEG TTM
- 0.39x
- Price / book
- 2.97x
- Price / sales
- 9.73x
- Price / cash flow
- 82.17x
Enterprise value
- Enterprise value
- $49.9B
- EV / sales
- 10.74x
- EV / EBITDA
- 52.48x
- EV / EBIT
- 134.98x
- Market cap
- $45.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Oct 1, 2026